Coalition to Cure Calpain 3

Overcoming Weakness with Strength

Menu

  • About Us
  • Research
  • For Patients
  • News
  • Donate Now

Awareness

C3 Celebrates Rare Disease Day

Jennifer Levy February 28, 2025February 28, 2025 Awareness, C3 News Read more

What can YOU do to drive LGMD2A/R1 research forward? Participate in a natural history study!

What is a natural history study? A natural history study is a research study that collects information about the genetics, symptoms, and lived experiences of individuals. These studies are considered observational, because they do not include an interventional drug or

Jennifer Levy October 18, 2024October 21, 2024 Awareness, Clinical research study Read more

C3 celebrates 10th annual LGMD Awareness Day!

There is great strength in awareness, understanding, and unity. The LGMD community demonstrates global connectivity each year when we campaign together and gain recognition for LGMD. With over 30 different genetic types of LGMD, the act of collaborating globally makes

Jennifer Levy September 30, 2024September 30, 2024 Awareness, C3 News Read more

May 20 is Clinical Trials Day

On this day, C3 would like to take the opportunity to discuss the DRUG DEVELOPMENT PROCESS for rare diseases such as LGMD2A/R1. DISCOVERY: Drug development usually begins in the laboratory, where researchers seek to gain new insights into a disease process. With a

Jennifer Levy May 20, 2023May 19, 2023 Awareness Read more

Join Coalition to Cure Calpain 3 in celebrating Rare Disease Day

Rare Disease Day takes place on the last day of February every year, with the goal of raising awareness about rare diseases and their impact on patients’ lives. Over 300 million people are living with one or more of over

Jennifer Levy February 27, 2023February 27, 2023 Awareness Read more

C3 partners with 16 LGMD organizations in letter to FDA

Coalition to Cure Calpain 3 is proud to be one of 17 organizations dedicated to LGMD to have collaborated on a statement submitted to the Food and Drug Administration in conjunction with the recent Patient-Focused Drug Development Meeting Patient Perspectives

Jennifer Levy December 19, 2022December 19, 2022 Awareness, C3 News, Patient-focused drug development Read more

Your voice made a difference!

THANK YOU to all those families impacted by limb-girdle muscular dystrophy types 2A, 2C, 2D, 2E, 2F, and 2I who made their voices heard at the LGMD EL-PFDD! Whether you were on camera, called in, submitted written comments, or participated

Jennifer Levy September 27, 2022September 27, 2022 Awareness, C3 News, Patient-focused drug development Read more

Together we are STRONGER: 8th Annual LGMD Awareness Day is coming up!

There is great strength in awareness, understanding, and unity. The LGMD community demonstrates global connectivity each year when we campaign together and gain recognition for LGMD. With over 30 different genetic types of LGMD, the act of collaborating globally makes

Jennifer Levy September 1, 2022August 30, 2022 Awareness, C3 News, Uncategorized Read more

Daniel Ferguson LGMD Foundation Launches

C3 is pleased to share the launch of an Australian-based organization, the Daniel Ferguson LGMD Foundation. This registered charity aims to improve the lives of those living with LGMD2A/R1 by improving awareness, increasing genetic testing, and enabling those living with

Jennifer Levy March 1, 2022March 1, 2022 Awareness Read more

Join Coalition to Cure Calpain 3 in celebrating Rare Disease Day!

Rare Disease Day takes place on the last day of February every year, with the goal of raising awareness about rare diseases and their impact on patients’ lives. Over 300 million people are living with one or more of over

Jennifer Levy February 28, 2022February 28, 2022 Awareness, C3 News Read more
  • « Previous

Recent Posts

  • Community Health Clinic publishes newsletter focused on LGMDs
  • New Research Alert: GRASP-001 Study
  • Upcoming Event: International LGMD Conference
  • Sarepta Community Update on LGMD Programs
  • C3 Celebrates Rare Disease Day

Recent Comments

    Archives

    • May 2025
    • April 2025
    • February 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • July 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • December 2022
    • November 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • November 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • July 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • February 2019
    • January 2019
    • November 2018
    • October 2018
    • September 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017

    Categories

    • 10 Years of Progress
    • Awareness
    • C3 News
    • Clinical research study
    • Disease models
    • Funding opportunity
    • genetic testing
    • Genetics
    • Patient-focused drug development
    • Research Projects
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Subscribe to Blog via Email

    Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Copyright © 2025 Coalition to Cure Calpain 3. Powered by WordPress. Theme: Spacious by ThemeGrill.
    • Privacy Policy
    en English
    am አማርኛar العربيةzh-CN 简体中文zh-TW 繁體中文da Dansknl Nederlandsen Englishfr Françaisde Deutschiw עִבְרִיתhi हिन्दीit Italianoja 日本語km ភាសាខ្មែរko 한국어ku كوردی‎mr मराठीno Norsk bokmålpl Polskipt Portuguêspa ਪੰਜਾਬੀru Русскийes Españolsv Svenskata தமிழ்te తెలుగుtr Türkçe